Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment
PLOS Global Public Health · 02.05.2024 · 4 (5) · e0003168
DOI: 10.1371/journal.pgph.0003168 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 02.05.2024. Verfasst von Sanjay Basu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vulnerable Populations, University of California San Francisco, San Francisco, California, United States of America. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Department for International Development, UK Government.
Abstract (Originalsprache)
We sought to assess the effectiveness and cost-effectiveness of potential new public health and healthcare NCD risk reduction efforts among Palestinians in Gaza. We created a microsimulation model using: (i) a cross-sectional household survey of NCD risk factors among 4,576 Palestinian adults aged ≥40 years old in Gaza; (ii) a modified Delphi process among local public health experts to identify potentially feasible new interventions; and (iii) reviews of intervention cost and effectiveness, modified to the Gazan and refugee contexts. The survey revealed 28.6% tobacco smoking, a 40.4% prevalence of hypertension diagnosis (with a 95.6% medication treatment rate), a 25.6% prevalence of diabetes diagnosis (with 95.3% on treatment), a 21.9% prevalence of dyslipidemia (with 79.6% on a statin), and a 9.8% prevalence of asthma or chronic obstructive pulmonary disease (without known treatment). A calibrated model estimated a loss of 9,516 DALYs per 10,000 population over the 10-year policy horizon. The interventions having an incremental cost-effectiveness ratio (ICER) less than three times the GDP per capita of Palestine per DALY averted (
Autor:innen und Institutionen
- Center for Vulnerable Populations, University of California San Francisco, San Francisco, California, United States of America.
- Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada.
- Division of Medicine, Institute of Cardiovascular Science, University College London, London, United Kingdom.
- Public Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, United Kingdom.
- Center for Research on Population and Health, American University of Beirut, Beirut, Lebanon.
- Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.
ORCID-Profile: Sanjay Basu
Förderung
- Wellcome Trust
- Medical Research Council
- Department for International Development, UK Government
- Economic and Social Research Council
Zitieren
APA
Basu, S., Yudkin, J. S., Jawad, M., Ghattas, H., Hamad, B. A., Jamaluddine, Z., Safadi, G., Ragi, M. E., Ahmad, R. E. S., Vamos, E. P., & Millett, C. (2024). Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment. PLOS Global Public Health, 4(5), e0003168. https://doi.org/10.1371/journal.pgph.0003168
Vancouver
Basu S, Yudkin JS, Jawad M, Ghattas H, Hamad BA, Jamaluddine Z, et al. Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment. PLOS Global Public Health. 2024;4(5):e0003168. doi:10.1371/journal.pgph.0003168
BibTeX
@article{Basu2024,
author = {Basu, Sanjay and Yudkin, John S and Jawad, Mohammed and Ghattas, Hala and Hamad, Bassam Abu and Jamaluddine, Zeina and Safadi, Gloria and Ragi, Marie-Elizabeth and Ahmad, Raeda El Sayed and Vamos, Eszter P and Millett, Christopher},
title = {Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment},
journal = {PLOS Global Public Health},
year = {2024},
volume = {4},
number = {5},
pages = {e0003168},
doi = {10.1371/journal.pgph.0003168}
}
EUVIMED